4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-127074
Options or other derivatives
- Director acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| King Rachel K. Director | 2024-11-12 | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…